155 related articles for article (PubMed ID: 18772695)
1. Low bone mineral density in spinal muscular atrophy.
Khatri IA; Chaudhry US; Seikaly MG; Browne RH; Iannaccone ST
J Clin Neuromuscul Dis; 2008 Sep; 10(1):11-7. PubMed ID: 18772695
[TBL] [Abstract][Full Text] [Related]
2. Secondary Bone Defect in Neuromuscular Diseases in Childhood: A Longitudinal "Muscle-Bone Unit" Analysis.
Ribstein C; Courteix D; Rabiau N; Bommelaer C; Bourdeau Y; Pereira B; Sarret C
Neuropediatrics; 2018 Dec; 49(6):397-400. PubMed ID: 29980148
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and its influencing factors in Chinese children with spinal muscular atrophy types 2 and 3.
Peng X; Qu Y; Li X; Liu J; Shan X; Wang J; Song F
BMC Musculoskelet Disord; 2021 Aug; 22(1):729. PubMed ID: 34429096
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
5. Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity.
Wasserman HM; Hornung LN; Stenger PJ; Rutter MM; Wong BL; Rybalsky I; Khoury JC; Kalkwarf HJ
Neuromuscul Disord; 2017 Apr; 27(4):331-337. PubMed ID: 28258940
[TBL] [Abstract][Full Text] [Related]
6. Spinal bone mineral density, IGF-1 and IGFBP-3 in children with cerebral palsy.
Ali O; Shim M; Fowler E; Cohen P; Oppenheim W
Horm Res; 2007; 68(6):316-20. PubMed ID: 17912004
[TBL] [Abstract][Full Text] [Related]
7. Bone and Spinal Muscular Atrophy.
Vai S; Bianchi ML; Moroni I; Mastella C; Broggi F; Morandi L; Arnoldi MT; Bussolino C; Baranello G
Bone; 2015 Oct; 79():116-20. PubMed ID: 26055105
[TBL] [Abstract][Full Text] [Related]
8. Osteopenia and fractures in cystinotic children post renal transplantation.
Zimakas PJ; Sharma AK; Rodd CJ
Pediatr Nephrol; 2003 Apr; 18(4):384-90. PubMed ID: 12700967
[TBL] [Abstract][Full Text] [Related]
9. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
[TBL] [Abstract][Full Text] [Related]
10. Correlates of osteopenia in patients with cystic fibrosis.
Bhudhikanok GS; Lim J; Marcus R; Harkins A; Moss RB; Bachrach LK
Pediatrics; 1996 Jan; 97(1):103-11. PubMed ID: 8545201
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in juvenile dermatomyositis: assessment using dual x-ray absorptiometry.
Stewart WA; Acott PD; Salisbury SR; Lang BA
Arthritis Rheum; 2003 Aug; 48(8):2294-8. PubMed ID: 12905484
[TBL] [Abstract][Full Text] [Related]
12. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
Abeş M; Sarihan H; Madenci E
J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
[TBL] [Abstract][Full Text] [Related]
14. Bone density and alendronate effects in Duchenne muscular dystrophy patients.
Houston C; Mathews K; Shibli-Rahhal A
Muscle Nerve; 2014 Apr; 49(4):506-11. PubMed ID: 23835890
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in a paediatric spinal muscular atrophy population.
Kinali M; Banks LM; Mercuri E; Manzur AY; Muntoni F
Neuropediatrics; 2004 Dec; 35(6):325-8. PubMed ID: 15627939
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density correlation with fractures in nonambulatory pediatric patients.
Khoury DJ; Szalay EA
J Pediatr Orthop; 2007; 27(5):562-6. PubMed ID: 17585268
[TBL] [Abstract][Full Text] [Related]
18. [Bone mineral density in inflammatory bowel diseases in children].
Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study.
Moretti A; Liguori S; Paoletta M; Gimigliano F; Iolascon G
Adv Ther; 2022 Jul; 39(7):3308-3315. PubMed ID: 35614293
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
